Molecular biological analysis of the factors involved in the diagnosis, therapeutic effect prediction and prognosis of biliary tract and pancreatic tumor

Molecular biological analysis of the factors involved in the diagnosis, therapeutic effect prediction and prognosis of biliary tract and pancreatic tumor - Molecular biological analysis of biliary tract and pancreatic tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019259

Enrollment

500

Registered

2015-10-10

Start date

2015-10-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary tract and pancreatic tumor

Interventions

Blood collection of peripheral blood

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Biliary tract and pancreatic tumor patients, biliary tract and pancreatic inflammatory disease patients, multiple sclerosis patients, and healthy volunteers. Following conditions are needed for inclusion; (1) more than 20 years old. (2) the consent of participation in this study is obtained as a writing document from participant or the family.

Exclusion criteria

Exclusion criteria: Patients who are clearly expected to develop fatal complications by blood sampling.

Design outcomes

Primary

Measure	Time frame
Diagnostic method: the relationship between the analyzing factors and pathological diagnosis Chemosensitivity: the relationship between the analyzing factors and the chemosensitivity evaluated by RECIST guidelines version 1.1 Prognosis: the relationship between the analyzing factors and overall survival	—

Countries

Japan

Contacts

Public ContactShingo Kato

Yokohma City University Hospital Department of Gastroenterology and Hepatology

shin800m@yokohama-cu.ac.jp+81-45-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026